Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7813572rdf:typepubmed:Citationlld:pubmed
pubmed-article:7813572lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C0003842lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C0013443lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C0042397lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C0028066lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:7813572lifeskim:mentionsumls-concept:C1549542lld:lifeskim
pubmed-article:7813572pubmed:issue1-2lld:pubmed
pubmed-article:7813572pubmed:dateCreated1995-2-8lld:pubmed
pubmed-article:7813572pubmed:abstractTextThe relative importance of extracellular Ca2+ influx and intracellular Ca2+ release for the vasoconstrictor response to Sgd 101/75 (4(2-imidazoline-amino)-2-methyl-indazol-chlorhydrate), an alpha 1-adrenoceptor agonist, was examined in perfused rabbit ear arteries. Sdg 101/75 induced a phasic and a tonic vasoconstrictor response in a concentration-dependent manner. It is a full agonist on the tonic response but a partial agonist on the phasic response. Nifedipine preferentially inhibited the tonic but not the phasic response to Sgd 101/75. Therefore, Sgd 101/75 appears to require both the intracellular Ca2+ release and extracellular Ca2+ influx for its phasic and tonic responses in rabbit ear arteries, respectively.lld:pubmed
pubmed-article:7813572pubmed:languageenglld:pubmed
pubmed-article:7813572pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813572pubmed:citationSubsetIMlld:pubmed
pubmed-article:7813572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813572pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813572pubmed:statusMEDLINElld:pubmed
pubmed-article:7813572pubmed:monthSeplld:pubmed
pubmed-article:7813572pubmed:issn0014-2999lld:pubmed
pubmed-article:7813572pubmed:authorpubmed-author:WongP CPClld:pubmed
pubmed-article:7813572pubmed:authorpubmed-author:TimmermansP...lld:pubmed
pubmed-article:7813572pubmed:authorpubmed-author:HarkS KSKlld:pubmed
pubmed-article:7813572pubmed:issnTypePrintlld:pubmed
pubmed-article:7813572pubmed:day1lld:pubmed
pubmed-article:7813572pubmed:volume262lld:pubmed
pubmed-article:7813572pubmed:ownerNLMlld:pubmed
pubmed-article:7813572pubmed:authorsCompleteYlld:pubmed
pubmed-article:7813572pubmed:pagination185-8lld:pubmed
pubmed-article:7813572pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:meshHeadingpubmed-meshheading:7813572-...lld:pubmed
pubmed-article:7813572pubmed:year1994lld:pubmed
pubmed-article:7813572pubmed:articleTitleEffects of nifedipine on phasic and tonic vasoconstrictor responses to Sgd 101/75 in the isolated perfused rabbit ear artery.lld:pubmed
pubmed-article:7813572pubmed:affiliationDuPont Merck Pharmaceutical Company, Wilmington, DE 19880-0400.lld:pubmed
pubmed-article:7813572pubmed:publicationTypeJournal Articlelld:pubmed